VANDA PHARMACEUTICALS INC. (VNDA) Free cash flow 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$110.4MFY2025 · since FY2016: -$9.5M → -$110.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$110.4M | -579.8% |
| FY2024 | -$16.2M | -230.8% |
| FY2023 | $12.4M | -60.3% |
| FY2022 | $31.3M | -50.8% |
| FY2021 | $63.7M | +27.4% |
| FY2020 | $50.0M | +11.2% |
| FY2019 | $44.9M | +51.7% |
| FY2018 | $29.6M | +912.1% |
| FY2017 | -$3.6M | +61.7% |
| FY2016 | -$9.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating incomeVNDA Operating marginVNDA Operating cash flowVNDA Capital expendituresVNDA Return on equityVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Total liabilitiesVNDA Shareholders’ equityVNDA overview →